Search Results - "Rudraraju, Rajeev"

Refine Results
  1. 1
  2. 2
  3. 3

    Passive immunization with influenza haemagglutinin specific monoclonal antibodies by Rudraraju, Rajeev, Subbarao, Kanta

    Published in Human vaccines & immunotherapeutics (02-11-2018)
    “…The isolation of broadly neutralising antibodies against the influenza haemagglutinin has spurred investigation into their clinical potential, and has led to…”
    Get full text
    Journal Article
  4. 4

    Respiratory syncytial virus human experimental infection model: provenance, production, and sequence of low-passaged memphis-37 challenge virus by Kim, Young-In, DeVincenzo, John P, Jones, Bart G, Rudraraju, Rajeev, Harrison, Lisa, Meyers, Rachel, Cehelsky, Jeff, Alvarez, Rene, Hurwitz, Julia L

    Published in PloS one (21-11-2014)
    “…Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in children and is responsible for as many as 199,000 childhood…”
    Get full text
    Journal Article
  5. 5

    Respiratory tract epithelial cells express retinaldehyde dehydrogenase ALDH1A and enhance IgA production by stimulated B cells in the presence of vitamin A by Rudraraju, Rajeev, Jones, Bart G, Surman, Sherri L, Sealy, Robert E, Thomas, Paul G, Hurwitz, Julia L

    Published in PloS one (22-01-2014)
    “…Morbidity and mortality due to viral infections are major health concerns, particularly when individuals are vitamin A deficient. Vitamin A deficiency…”
    Get full text
    Journal Article
  6. 6

    Reduced Frequencies and Heightened CD103 Expression among Virus-Induced CD8+ T Cells in the Respiratory Tract Airways of Vitamin A-Deficient Mice by Rudraraju, Rajeev, Surman, Sherri L, Jones, Bart G, Sealy, Robert, Woodland, David L, Hurwitz, Julia L

    Published in Clinical and Vaccine Immunology (01-05-2012)
    “…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  7. 7

    Respiratory syncytial virus: current progress in vaccine development by Rudraraju, Rajeev, Jones, Bart G, Sealy, Robert, Surman, Sherri L, Hurwitz, Julia L

    Published in Viruses (05-02-2013)
    “…Respiratory syncytial virus (RSV) is the etiological agent for a serious lower respiratory tract disease responsible for close to 200,000 annual deaths…”
    Get full text
    Journal Article Book Review
  8. 8

    Convalescent plasma treatment for COVID‐19: Tempering expectations with the influenza experience by Subbarao, Kanta, Mordant, Francesca, Rudraraju, Rajeev

    Published in European journal of immunology (01-10-2020)
    “…The COVID‐19 pandemic caused by the zoonotic coronavirus, SARS‐CoV‐2 has swept the world in 5 months. A proportion of cases develop severe respiratory tract…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection by Vanslambrouck, Jessica M, Neil, Jessica A, Rudraraju, Rajeev, Mah, Sophia, Tan, Ker Sin, Groenewegen, Ella, Forbes, Thomas A, Karavendzas, Katerina, Elliott, David A, Porrello, Enzo R, Subbarao, Kanta, Little, Melissa H

    Published in Journal of virology (19-03-2024)
    “…With a high incidence of acute kidney injury among hospitalized COVID-19 patients, considerable attention has been focussed on whether SARS-CoV-2 specifically…”
    Get full text
    Journal Article
  12. 12

    Sendai virus-based RSV vaccine protects African green monkeys from RSV infection by Jones, Bart G, Sealy, Robert E, Rudraraju, Rajeev, Traina-Dorge, Vicki L, Finneyfrock, Brad, Cook, Anthony, Takimoto, Toru, Portner, Allen, Hurwitz, Julia L

    Published in Vaccine (20-01-2012)
    “…Highlights ► SeVRSV, a recombinant Sendai virus expressing RSV F, was tested in AGM. ► SeVRSV elicited antibody responses against SeV and RSV. ► SeVRSV fully…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Intranasal administration of retinyl palmitate with a respiratory virus vaccine corrects impaired mucosal IgA response in the vitamin A-deficient host by Surman, Sherri L, Jones, Bart G, Rudraraju, Rajeev, Sealy, Robert E, Hurwitz, Julia L

    Published in Clinical and vaccine immunology (01-04-2014)
    “…Our previous studies showed that intranasal vaccination of vitamin A-deficient (VAD) mice failed to induce normal levels of upper respiratory tract IgA, a…”
    Get full text
    Journal Article
  16. 16

    Phenotypes and functions of persistent Sendai virus-induced antibody forming cells and CD8+ T cells in diffuse nasal-associated lymphoid tissue typify lymphocyte responses of the gut by Rudraraju, Rajeev, Surman, Sherri, Jones, Bart, Sealy, Robert, Woodland, David L, Hurwitz, Julia L

    Published in Virology (New York, N.Y.) (20-02-2011)
    “…Abstract Lymphocytes of the diffuse nasal-associated lymphoid tissue (d-NALT) are uniquely positioned to tackle respiratory pathogens at their point-of-entry,…”
    Get full text
    Journal Article
  17. 17

    Antigen presenting cell‐targeted proinsulin expression converts insulin‐specific CD8+ T‐cell priming to tolerance in autoimmune‐prone NOD mice by Reeves, Peta L. S., Rudraraju, Rajeev, Wong, F. Susan, Hamilton‐Williams, Emma E., Steptoe, Raymond J.

    Published in European journal of immunology (01-09-2017)
    “…Type 1 diabetes (T1D) results from autoimmune destruction of insulin‐producing pancreatic β cells. Therapies need to incorporate strategies to overcome the…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Deciphering and correcting impaired respiratory virus-specific immunity caused by vitamin A deficiency (VIR2P.1017) by Penkert, Rhiannon, Surman, Sherri, Jones, Bart, Sealy, Robert, Neale, Geoffrey, Rudraraju, Rajeev, Hurwitz, Julia

    Published in The Journal of immunology (1950) (01-05-2014)
    “…Abstract Vitamin A deficiency (VAD) is a leading contributor to pediatric morbidity and mortality worldwide. Recently we have shown that VAD in mice impairs…”
    Get full text
    Journal Article
  20. 20

    Single-shot immunization with recombinant adenovirus encoding vaccinia virus glycoprotein A27L is protective against a virulent respiratory poxvirus infection by Rudraraju, Rajeev, Ramsay, Alistair J

    Published in Vaccine (12-07-2010)
    “…Abstract Significant safety issues have emerged concerning the general use of DRYVAX® vaccine. Vaccination with replication-defective recombinant adenovirus…”
    Get full text
    Journal Article